These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31264439)

  • 1. TNS1-ALK Fusion in a Recurrent, Metastatic Uterine Mesenchymal Tumor Originally Diagnosed as Leiomyosarcoma.
    Lee J; Singh A; Ali SM; Lin DI; Klempner SJ
    Acta Med Acad; 2019 Apr; 48(1):116-120. PubMed ID: 31264439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors.
    Ptáková N; Miesbauerová M; Kosťun J; Grossmann P; Šidlová H; Pavelka J; Presl J; Alaghehbandan R; Bouda J; Ondič O
    Virchows Arch; 2018 Nov; 473(5):583-590. PubMed ID: 30116888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
    Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
    Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion.
    Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E
    Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib.
    Carballo EV; Pham TV; Turashvili G; Hanley K; Starbuck KD; Meisel JL
    Gynecol Oncol Rep; 2022 Oct; 43():101062. PubMed ID: 36032811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
    Shintaku M; Fukushima A
    Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myofibroblastic tumor of the uterus - case report.
    Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
    Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
    Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
    Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma.
    Davis LE; Nusser KD; Przybyl J; Pittsenbarger J; Hofmann NE; Varma S; Vennam S; Debiec-Rychter M; van de Rijn M; Davare MA
    Mol Cancer Res; 2019 Mar; 17(3):676-685. PubMed ID: 30518629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
    Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
    Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
    Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
    Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Myofibroblastic Tumor Driven by Novel
    Rao N; Iwenofu H; Tang B; Woyach J; Liebner DA
    J Natl Compr Canc Netw; 2018 Feb; 16(2):115-121. PubMed ID: 29439172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.
    Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T
    Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms.
    Chiang S
    Genes Chromosomes Cancer; 2021 Mar; 60(3):138-146. PubMed ID: 33230916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review.
    Olgan S; Saatli B; Okyay RE; Koyuncuoglu M; Dogan E
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):234-6. PubMed ID: 21439710
    [No Abstract]   [Full Text] [Related]  

  • 18. [A peculiar intra-uterine lesion: Inflammatory myofibroblastic tumor (IMT)].
    Kesrouani C; Zemoura L; Laé M
    Ann Pathol; 2018 Apr; 38(2):143-146. PubMed ID: 29397221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
    Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
    Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine inflammatory myofibroblastic tumor with THBS1-INSR fusion.
    Sim A; Devouassoux-Shisheboran M; Benmoulay-Rigollot C; Picot T; Péoc'h M; Karpathiou G
    Pathol Res Pract; 2023 Jun; 246():154500. PubMed ID: 37156213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.